Esperion Therapeutics
ESPR
#6533
Rank
โ‚น67.63 B
Marketcap
โ‚น285.28
Share price
0.48%
Change (1 day)
49.35%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: โ‚น67.63 Billion

As of January 2026 Esperion Therapeutics has a market cap of โ‚น67.63 Billion. This makes Esperion Therapeutics the world's 6533th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น67.63 B-21.34%
2025โ‚น85.97 B123.09%
2024โ‚น38.53 B36.15%
2023โ‚น28.30 B-25.48%
2022โ‚น37.98 B67.6%
2021โ‚น22.66 B-54.01%
2020โ‚น49.27 B-57.86%
2019โ‚น116.92 B35.52%
2018โ‚น86.28 B-21.66%
2017โ‚น110.13 B473.95%
2016โ‚น19.18 B-42.39%
2015โ‚น33.30 B-36.12%
2014โ‚น52.14 B300.4%
2013โ‚น13.02 B

End of Day market cap according to different sources

On Jan 15th, 2026 the market cap of Esperion Therapeutics was reported to be:

โ‚น67.87 Billion
by Nasdaq info icon info icon
โ‚น67.30 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚น206.53 B 205.38%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น958.80 B 1,317.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น13.267 T 19,516.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น7.068 T 10,351.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น402.18 B 494.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น43.51 B-35.66%๐Ÿ‡บ๐Ÿ‡ธ USA